Stay updated on SMA Biomarker Study Clinical Trial
Sign up to get notified when there's something new on the SMA Biomarker Study Clinical Trial page.

Latest updates to the SMA Biomarker Study Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record area continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedAn NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in agency content. The clinical trial record is still replaced by a 403 Forbidden error.SummaryDifference1%

- Check20 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the 403 access-denied page otherwise remains unchanged.SummaryDifference0.2%

- Check48 days agoChange DetectedA 403 Forbidden page is now shown for the study URL, blocking access to the study content. The visible page chrome (header/footer) remains, indicating an access issue rather than an update to the study information.SummaryDifference19%

- Check69 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This represents a minor metadata update to the record and does not alter the study information.SummaryDifference0.1%

Stay in the know with updates to SMA Biomarker Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMA Biomarker Study Clinical Trial page.